Form 4: Journey Medical Corp CEO Claude Maraoui Sells Shares to Cover Tax Obligations

CEO Claude Maraoui sold shares of Journey Medical Corp stock to cover tax obligations related to vesting restricted stock units.

Summary

• Claude Maraoui, the President and CEO of Journey Medical Corp, sold shares of the company's common stock on March 6 and March 7, 2025.
• The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• On March 6, 2025, 25,551 shares were sold at a weighted average price of $5.04, with prices ranging from $5.00 to $5.26.
• On March 7, 2025, 14,905 shares were sold at a weighted average price of $5.01, with prices ranging from $4.99 to $5.14.
• Following these transactions, Maraoui directly owns 2,052,418 shares of Journey Medical Corp.
• The sales were conducted automatically according to the Issuer's corporate policies regarding the vesting of restricted stock units, and the Reporting Person had no discretion with respect to such sale.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing related to stock sales for tax purposes. It doesn't convey strong positive or negative sentiment, but the fact that the CEO is selling shares, even for tax purposes, could be perceived slightly negatively.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market.

Key Dates